FDA approves Abbott CGMs for use during medical imaging
October 30, 2024
Abbott (NYSE:ABT) today announced a significant regulatory milestone that could make common medical procedures easier for people with diabetes.
Abbott (NYSE:ABT) today announced a significant regulatory milestone that could make common medical procedures easier for people with diabetes.
CytexOrtho today said it has approval from the FDA to start a Phase 1 clinical trial evaluating the safety and efficacy of its absorbable hip implant in human patients.
Paragonix Technologies this week announced it received FDA 510(k) clearance for its KidneyVault donor kidney preservation system.
Insulet (Nasdaq:PODD) Omnipod 5 users now have a new way to control their automated insulin delivery system.
Novosound today announced the unveiling of an ultrasonic blood pressure monitor, miniaturizing blood pressure monitoring in wearable devices.
Distalmotion announced today that it received FDA de novo approval for its Dexter surgical robot for adult inguinal hernia repair.
Vantis Vascular announced today that it received FDA 510(k) clearance for its CrossFast integrated microcatheter guide extension system.
Dexcom’s third-quarter earnings report included news of a significant submission to the FDA for the company’s latest-generation technology.
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Evolut FX+ transcatheter aortic valve implantation (TAVI) system.
MOUNTAIN VIEW, Calif., Oct. 24, 2024 /PRNewswire/ — In a groundbreaking advancement for medical science, surgeons in Santiago, Chile, performed the world’s first robotic surgeries combining 3D visualization and augmented reality (AR), marking a significant step forward in improving surgical speed, visualization, precision, and patient outcomes.